Davis R. Ingram

4.1k total citations
59 papers, 1.8k citations indexed

About

Davis R. Ingram is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Davis R. Ingram has authored 59 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 29 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Davis R. Ingram's work include Sarcoma Diagnosis and Treatment (36 papers), Vascular Tumors and Angiosarcomas (12 papers) and Cardiac tumors and thrombi (9 papers). Davis R. Ingram is often cited by papers focused on Sarcoma Diagnosis and Treatment (36 papers), Vascular Tumors and Angiosarcomas (12 papers) and Cardiac tumors and thrombi (9 papers). Davis R. Ingram collaborates with scholars based in United States, Canada and Netherlands. Davis R. Ingram's co-authors include Alexander J. Lazar, Wei‐Lien Wang, Keila E. Torres, Dina Lev, Elizabeth G. Demicco, Raphael E. Pollock, Neeta Somaiah, Ghadah Al Sannaa, Kelsey L. Watson and Jason L. Hornick and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Molecular Cell.

In The Last Decade

Davis R. Ingram

54 papers receiving 1.8k citations

Peers

Davis R. Ingram
Davis R. Ingram
Citations per year, relative to Davis R. Ingram Davis R. Ingram (= 1×) peers Anne Gomez‐Brouchet

Countries citing papers authored by Davis R. Ingram

Since Specialization
Citations

This map shows the geographic impact of Davis R. Ingram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davis R. Ingram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davis R. Ingram more than expected).

Fields of papers citing papers by Davis R. Ingram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davis R. Ingram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davis R. Ingram. The network helps show where Davis R. Ingram may publish in the future.

Co-authorship network of co-authors of Davis R. Ingram

This figure shows the co-authorship network connecting the top 25 collaborators of Davis R. Ingram. A scholar is included among the top collaborators of Davis R. Ingram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davis R. Ingram. Davis R. Ingram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lazcano, Rossana, et al.. (2024). TRPS1 expression in MPNST is correlated with PRC2 inactivation and loss of H3K27me3. Human Pathology. 151. 105632–105632.
2.
Denu, Ryan A., Ahsan Farooqi, Davis R. Ingram, et al.. (2024). Impact of ATRX loss on survival and immune microenvironment in multiple sarcoma subtypes.. Journal of Clinical Oncology. 42(16_suppl). 11511–11511. 2 indexed citations
3.
Beird, Hannah C., Jeffrey M. Cloutier, Nalan Gökgöz, et al.. (2024). Epigenomic and Transcriptomic Profiling of Solitary Fibrous Tumors Identifies Site-Specific Patterns and Candidate Genes Regulated by DNA Methylation. Laboratory Investigation. 104(11). 102146–102146.
4.
Wangsiricharoen, Sintawat, et al.. (2024). Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Immunohistochemistry Can Be a Useful Ancillary Tool to Identify Perivascular Epithelioid Cell Tumor. Modern Pathology. 37(3). 100426–100426. 7 indexed citations
5.
Denu, Ryan A., Davis R. Ingram, Khalida Wani, et al.. (2024). DNA mismatch repair deficiency as a biomarker in sarcoma. PubMed. 1(4). 100091–100091.
6.
Hu, Jiemiao, Alexander J. Lazar, Davis R. Ingram, et al.. (2024). Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models. Journal for ImmunoTherapy of Cancer. 12(1). e006991–e006991. 19 indexed citations
7.
Nguyen, Tuyen Duong Thanh, Tuyen Bui, Rossana Lazcano, et al.. (2023). Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time. Cancer Research. 83(6). 939–955. 3 indexed citations
8.
Truong, Danh D., Salah-Eddine Lamhamedi-Cherradi, Mayinuer Maitituoheti, et al.. (2023). Abstract 1196: The epigenetic impact and therapeutic opportunity of AR-directed therapy for DSRCT. Cancer Research. 83(7_Supplement). 1196–1196. 1 indexed citations
9.
Beird, Hannah C., Chia-Chin Wu, Michael S. Nakazawa, et al.. (2023). Complete loss of TP53 and RB1 is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma. Human Genetics and Genomics Advances. 4(4). 100224–100224. 5 indexed citations
10.
Wu, Chia-Chin, Hannah C. Beird, Salah-Eddine Lamhamedi-Cherradi, et al.. (2022). Multi-site desmoplastic small round cell tumors are genetically related and immune-cold. npj Precision Oncology. 6(1). 21–21. 13 indexed citations
11.
Keung, Emily Z., Nadim J. Ajami, Sheila Duncan, et al.. (2021). 191P Fecal microbiome in soft-tissue sarcoma (STS) patients treated with neoadjuvant immune checkpoint blockade (ICB). Annals of Oncology. 32. S1464–S1464. 1 indexed citations
12.
Beird, Hannah C., Chia-Chin Wu, Davis R. Ingram, et al.. (2018). Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin. Molecular Case Studies. 4(2). a002386–a002386. 46 indexed citations
13.
McBride, Matthew J., John L. Pulice, Hannah C. Beird, et al.. (2018). The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma. Cancer Cell. 33(6). 1128–1141.e7. 173 indexed citations
14.
Dodd, Rebecca D., Chang‐Lung Lee, Wesley Huang, et al.. (2017). NF1+/− Hematopoietic Cells Accelerate Malignant Peripheral Nerve Sheath Tumor Development without Altering Chemotherapy Response. Cancer Research. 77(16). 4486–4497. 21 indexed citations
15.
Cleven, Arjen H.G., Ghadah Al Sannaa, Inge H. Briaire‐de Bruijn, et al.. (2016). Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival. Modern Pathology. 29(6). 582–590. 162 indexed citations
16.
Panse, Gauri, Cheuk Hong Leung, Davis R. Ingram, et al.. (2016). The role of phosphorylated signal transducer and activator of transcription 3 (pSTAT3) in peripheral nerve sheath tumours. Histopathology. 70(6). 946–953. 6 indexed citations
17.
Beird, Hannah C., Davis R. Ingram, Theresa Nguyen, et al.. (2016). Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation. Laboratory Investigation. 96(8). 885–894. 15 indexed citations
18.
Watson, Kelsey L., Ghadah Al Sannaa, Roman Belousov, et al.. (2015). Poly (ADP) ribose polymerase inhibition: A potential treatment of malignant peripheral nerve sheath tumor. Cancer Biology & Therapy. 17(2). 129–138. 11 indexed citations
19.
Satelli, Arun, Abhisek Mitra, Jeffry J. Cutrera, et al.. (2014). Universal Marker and Detection Tool for Human Sarcoma Circulating Tumor Cells. Cancer Research. 74(6). 1645–1650. 131 indexed citations
20.
Kotsmar, Csaba, et al.. (2010). Transport and Retention of Aqueous Dispersions of Paramagnetic Nanoparticles in Reservoir Rocks. SPE Improved Oil Recovery Symposium. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026